Kaleb Todd
Family Medicine Residency · SSM Health/Saint Louis University School of Medicine
Credentials: · · ·
History
Research
MCL1 inhibitors S63845/MIK665 plus Navitoclax synergistically kill difficult-to-treat melanoma cells
Cell Death and Disease · 2020 · 62 citations
Simultaneously Inhibiting BCL2 and MCL1 Is a Therapeutic Option for Patients with Advanced Melanoma
Cancers · 2020 · 27 citations
2 papers
2 papers
2 papers
1 paper
- RW
1 paper